Refine
Document Type
- Doctoral Thesis (2)
Language
- English (2) (remove)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- Enzymkatalyse (2) (remove)
Institute
In this thesis, all three BVMOs from Pseudomonas putida NCIMB10007, that were known to be responsible for the ability of this strain to degrade camphor since the 1950s were successfully made available as recombinant biocatalysts. While the genomic sequence of 2,5-DKCMO was available from the database, the genes encoding 3,6-DKCMO and OTEMO had to be identified using certain PCR-techniques first. All three enzymes were cloned into standard plasmids enabling convenient expression in E. coli facilitating the application of the enzymes in organic chemistry. Their synthetic potential was already reported during the 1990s, but at that time their efficient application was limited due to difficulties with respect to low production levels and insufficient purity and separation of enzyme fractions. These drawbacks are now overcome. Furthermore, biochemical characterization of the camphor-degrading BVMOs was performed including the substrate spectra of these enzymes. Thereby OTEMO turned out not only to have a broad substrate scope accepting mono- and bicyclic aliphatic and arylaliphatic ketones, but also to efficiently convert alpha/beta-unsaturated cycloalkanones due to the similarity of these compounds to OTEMOs natural substrate. Finally, the major limitation in the synthetic application of Type II BVMOs was addressed by searching a flavin-reductase suitable for coupling to these two-component oxygenases. Putative candidates from the respective P. putida strain were identified by the use of amino acid motifs conserved in other representatives of two-component systems. While these enzymes failed, flavin-reductase Fre from E. coli - that also contained the motifs - was shown to enhance the activity of the DKCMOs when applied as crude cell extract as well as pure enzyme. This finding represents a key step for future application of Type II BVMOs.
In this thesis an artificial enzyme cascade consisting of an ADH from Lactobacillus kefir, a CHMO from Acinetobacter sp. NCIMB 9871 and lipase A from Candida antarctica has been investigated for the biocatalytic synthesis of the bulk chemical ε-caprolactone as well as several derivatives for their direct utilization as polymer building blocks. Due to major limitations, which hamper such a biocatalytic route, the first addressed demand in this work was the improvement of the stability of the CHMO. By structure-guided engineering, distinctively improved variants concerning the resistance against oxidation as well as temperature stability without compromising the catalytic activity were successfully created. Due to the incomplete knowledge of the mechanisms that lead to thermal and/or oxidative inactivation of enzymes, this study illustrates that the selection of mutations for increased protein stability is still hard to predict. Thus, these results can serve as a basis for further stability studies on this enzyme class to give better insights into the underlying mechanisms, which determine the stability of an enzyme. Such a highly stabilized biocatalyst will pave the way for the successful use of flavin-dependent enzymes for industrial applications. A further aim of this thesis was dedicated to the second major hurdle en route to polyester precursors represented by the product inhibition and enzyme deactivation caused by ε-caprolactone, particularly at higher concentrations. To overcome this limitation, we developed an elegant solution in which the ε-caprolactone produced by the one-pot two-step enzymatic method is directly subjected to ring-opening polymerization using the unique lipase A from Candida antarctica. Applying this enzyme cascade in a whole cell biocatalysis in combination with an improved cofactor regeneration approach, the problem of product inhibition problem was efficiently solved leading to the formation of oligo-ε-caprolactone at more than 20 g/L when starting from 200 mM cyclohexanol. By a process development approach through solvent engineering it was found that biotransformations proceed much faster in an isooctane-containing biphasic solvent system when using free enzymes. Finally, the improved enzyme cascade was applied for the synthesis of chiral substrates and provided access to functionalized chiral compounds in high yields (up to >99%) and optical purities (up to >99%ee). By subsequent enzymatic enantioselective ring-opening of the enantiopure monomers, oligomeric lactones were successfully synthesized, which can be directly serve as building blocks for the polymer industry.